BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16028100)

  • 1. Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL).
    Lu R; Jia J; Bao L; Fu Z; Li G; Wang S; Wang Z; Jin M; Gao W; Yao Z
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):248-56. PubMed ID: 16028100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma.
    Yao Z; Lu R; Jia J; Zhao P; Yang J; Zheng M; Lu J; Jin M; Yang H; Gao W
    Peptides; 2006 Jun; 27(6):1167-72. PubMed ID: 16129512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.
    Wang C; Wang S; Lu R; Zhao L; Zhu ZF; Xu Q; Lv JQ; Wang LL; Fu Z; Lin G; Yao Z
    Anticancer Drugs; 2009 Aug; 20(7):534-42. PubMed ID: 19491661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tyroservatide inhibits the growth of human hepatocarcinoma in nude mice].
    Jia J; Lu R; Fu Z; Qiu S; Shi LX; Jian X; Liu JY; Li HQ; Che XC; Yao Z
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):426-8. PubMed ID: 17152487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402.
    Jia J; Lu R; Qiu S; Li H; Che X; Zhao P; Jin M; Yang H; Lin G; Yao Z
    Cancer Biol Ther; 2005 Sep; 4(9):993-7. PubMed ID: 16082190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyroserleutide tripeptide affects calcium homeostasis of human hepatocarcinoma BEL-7402 cells.
    Fu Z; Lu R; Li G; Zhao L; Gao W; Che X; Jian X; Zhou C; Yao Z
    Sci China C Life Sci; 2005 Oct; 48(5):523-30. PubMed ID: 16315604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.
    Li XL; Liu JY; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Jia J; Fu Z; Yao Z
    Invest New Drugs; 2008 Dec; 26(6):525-9. PubMed ID: 18264678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
    Jia JB; Wang WQ; Sun HC; Liu L; Zhu XD; Kong LQ; Chai ZT; Zhang W; Zhang JB; Xu HX; Zeng ZC; Wu WZ; Wang L; Tang ZY
    Invest New Drugs; 2011 Oct; 29(5):861-72. PubMed ID: 20414698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
    Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
    Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice.
    Liu H; Xu HW; Zhang YZ; Huang Y; Han GQ; Liang TJ; Wei LL; Qin CY; Qin CK
    World J Gastroenterol; 2015 Sep; 21(36):10367-74. PubMed ID: 26420963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
    Shi LX; Lu R; Wang L; Zhou CL; Xu Q; Zhu ZF; Ma R; Zhang HL; Jia J; Fu Z; Yao Z
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):725-8. PubMed ID: 19173797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo.
    Hu QY; Li JN; Song DQ; Wang YL; Bekesi G; Weisz I; Jiang JD
    Int J Oncol; 2004 Nov; 25(5):1289-96. PubMed ID: 15492817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9.
    Che X; Lu R; Fu Z; Sun Y; Zhu ZF; Li JP; Wang S; Jia J; Wang Q; Yao Z
    Drug Des Devel Ther; 2018; 12():3357-3368. PubMed ID: 30349190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro.
    Yao Z; Qiu S; Wang L; Lu R; Zhou CL; Zhao PP; Li HQ; Gao WY
    Cancer Immunol Immunother; 2006 Jan; 55(1):56-60. PubMed ID: 16091933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
    Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
    Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
    Qin Y; Liu JY; Li B; Peng WZ; Fu MD; Sun ZL; Sun ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):132-7. PubMed ID: 15079795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.